Clinical Trial Update: Pharmacokinetic Evaluation of Moxifloxacin IV to Enteral Switch Therapy in Intensive Care Patients [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study evaluating a switch from intravenous to enteral Moxifloxacin in intensive care patients with pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Pneumonia | Phase 2 | Status: COMPLETED